Ningbo MedicalSystem Biotechnology Co Ltd (300439) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥48.96 Million ≈ $7.16 Million USD) by net assets (CN¥2.95 Billion ≈ $431.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300439 stock market capitalisation for the company's overall valuation and market capitalisation.

Ningbo MedicalSystem Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Ningbo MedicalSystem Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ningbo MedicalSystem Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ningbo MedicalSystem Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Explore Ningbo MedicalSystem Biotechnology Co Lt earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shenzhen Sosen Electronics Co.Ltd. SHE:301002	-0.007x
WINBO-Dongjian Automotive Technology Co. Ltd. SHE:300978	0.083x
Sichuan Expressway Company Limited F:EXF1	0.060x
Hunan Chen Dian International Development Co Ltd SHG:600969	0.108x
Globalworth REIT LSE:GWI	0.027x
Beijing Haohan Data Technology Co. Ltd. A SHG:688292	N/A
Aurelia Metals Ltd AU:AMI	0.211x
ZJBC Information Technology Co Ltd SHE:000889	0.058x

Annual Cash Flow Conversion Efficiency for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. View Ningbo MedicalSystem Biotechnology Co Lt (300439) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.93 Billion ≈ $429.26 Million	CN¥397.81 Million ≈ $58.21 Million	0.136x	-42.06%
2023-12-31	CN¥2.71 Billion ≈ $396.07 Million	CN¥633.53 Million ≈ $92.71 Million	0.234x	+4.43%
2022-12-31	CN¥2.52 Billion ≈ $368.67 Million	CN¥564.67 Million ≈ $82.63 Million	0.224x	+3.95%
2021-12-31	CN¥2.39 Billion ≈ $349.84 Million	CN¥515.48 Million ≈ $75.43 Million	0.216x	-60.12%
2020-12-31	CN¥1.69 Billion ≈ $246.86 Million	CN¥912.07 Million ≈ $133.47 Million	0.541x	+24.86%
2019-12-31	CN¥1.39 Billion ≈ $203.16 Million	CN¥601.17 Million ≈ $87.97 Million	0.433x	+134.69%
2018-12-31	CN¥2.27 Billion ≈ $332.15 Million	CN¥418.80 Million ≈ $61.28 Million	0.185x	+428.61%
2017-12-31	CN¥2.29 Billion ≈ $334.63 Million	CN¥-128.40 Million ≈ $-18.79 Million	-0.056x	-4283.55%
2016-12-31	CN¥1.83 Billion ≈ $267.53 Million	CN¥2.45 Million ≈ $359.05K	0.001x	-99.03%
2015-12-31	CN¥1.29 Billion ≈ $188.39 Million	CN¥177.55 Million ≈ $25.98 Million	0.138x	-50.86%
2014-12-31	CN¥415.13 Million ≈ $60.75 Million	CN¥116.51 Million ≈ $17.05 Million	0.281x	-13.52%
2013-12-31	CN¥308.32 Million ≈ $45.12 Million	CN¥100.06 Million ≈ $14.64 Million	0.325x	+40.55%
2012-12-31	CN¥202.58 Million ≈ $29.64 Million	CN¥46.78 Million ≈ $6.85 Million	0.231x	-48.63%
2011-12-31	CN¥110.84 Million ≈ $16.22 Million	CN¥49.82 Million ≈ $7.29 Million	0.450x	--

About Ningbo MedicalSystem Biotechnology Co Ltd

SHE:300439 China Diagnostics & Research

Market Cap

$533.70 Million

CN¥3.65 Billion CNY

Market Cap Rank

#12016 Global

#3473 in China

Share Price

CN¥9.49

Change (1 day)

-0.52%

52-Week Range

CN¥8.01 - CN¥11.04

All Time High

CN¥49.34